Accelerated ischemic vascular retinopathy after intravitreally injected bevacizumab for central retinal vein occlusion in elderly patients

BACKGROUND: Ischemic changes in the retinal circulation are an uncommon but severe adverse vascular reaction to intravitreal bevacizumab (Avastin(®), Genentech, San Francisco, CA, USA/Roche, Basel, Switzerland) for central retinal vein occlusion (CRVO). In the two cases reported here, ischemic chang...

Descripción completa

Detalles Bibliográficos
Autores principales: Isola, Vincenzo, Pece, Alfredo, Massironi, Claudio, Reposi, Simone, Dimastrogiovanni, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589185/
https://www.ncbi.nlm.nih.gov/pubmed/23467497
http://dx.doi.org/10.2147/OPTH.S30156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589185/
https://www.ncbi.nlm.nih.gov/pubmed/23467497
http://dx.doi.org/10.2147/OPTH.S30156

Ejemplares similares